A cross-sectional study to evaluate the effectiveness of additional Risk Minimisation Measures: A Survey among surgeons to assess their knowledge and understanding of selected risks of InductOs (dibotermin alfa/ACS) in Europe

First published 24/12/2019

Last updated 23/07/2021

EU PAS number:

EUPAS32916

Study

Finalised

Documents

Study protocol

Initial protocol

Protocol_PASS_InductOs_ effectiveness aRMM

English (387.93 KB - PDF)View document

Study results

Summary_PASS

English (30.12 KB - PDF)View document

Study report

Other information

ENCePP Seal

ENCePP Seal documents

Secondary tabs